Drug information for CESAMET
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
1MG
Prescription
(Reference Drug)
NABILONE
nabilone
MEDA PHARMS
18677
2008-12-10 Letter
2006-05-18 Letter
2006-05-16 Label
Drug Adverse Effects information for CESAMET
Role code
Indications
Reaction
# Reports
C
ANXIETY
DRUG DEPENDENCE
3
C
ANXIETY
DRUG WITHDRAWAL SYNDROME
3
C
ANXIETY
SUBSTANCE ABUSE
3
C
ARTHRALGIA
DRUG DEPENDENCE
18
C
ARTHRALGIA
DRUG WITHDRAWAL SYNDROME
18
C
ARTHRALGIA
SUBSTANCE ABUSE
18
C
ASTHMA
DRUG DEPENDENCE
1
C
ASTHMA
DRUG WITHDRAWAL SYNDROME
1
C
ASTHMA
SUBSTANCE ABUSE
1
C
BREAKTHROUGH PAIN
DRUG DEPENDENCE
5
C
BREAKTHROUGH PAIN
DRUG WITHDRAWAL SYNDROME
5
C
BREAKTHROUGH PAIN
SUBSTANCE ABUSE
5
C
CONTRACEPTION
FISTULA
1
C
CONTRACEPTION
INCISION SITE INFECTION
1
C
CONTRACEPTION
INTESTINAL OBSTRUCTION
1
C
CONTRACEPTION
INTESTINAL STENOSIS
1
C
CONTRACEPTION
NEURALGIA
1
C
CROHN'S DISEASE
FISTULA
3
C
CROHN'S DISEASE
INCISION SITE INFECTION
3
C
CROHN'S DISEASE
INTESTINAL OBSTRUCTION
3
C
CROHN'S DISEASE
INTESTINAL STENOSIS
3
C
CROHN'S DISEASE
NEURALGIA
3
C
DEPRESSION
DRUG DEPENDENCE
2
C
DEPRESSION
DRUG WITHDRAWAL SYNDROME
2
C
DEPRESSION
FISTULA
2
C
DEPRESSION
INCISION SITE INFECTION
2
C
DEPRESSION
INTESTINAL OBSTRUCTION
2
C
DEPRESSION
INTESTINAL STENOSIS
2
C
DEPRESSION
NEURALGIA
2
C
DEPRESSION
SUBSTANCE ABUSE
2
C
INSOMNIA
DRUG DEPENDENCE
2
C
INSOMNIA
DRUG WITHDRAWAL SYNDROME
2
C
INSOMNIA
SUBSTANCE ABUSE
2
C
MENOPAUSE
ALANINE AMINOTRANSFERASE INCREASED
1
C
MENOPAUSE
ANAEMIA POSTOPERATIVE
1
C
MENOPAUSE
ANGIOPLASTY
1
C
MENOPAUSE
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
MENOPAUSE
ASTHENIA
1
C
MENOPAUSE
BACK PAIN
1
C
MENOPAUSE
BLOOD ALKALINE PHOSPHATASE INCREASED
1
C
MENOPAUSE
BONE DISORDER
1
C
MENOPAUSE
DIARRHOEA
1
C
MENOPAUSE
GAMMA-GLUTAMYLTRANSFERASE INCREASED
1
C
MENOPAUSE
GASTROOESOPHAGEAL REFLUX DISEASE
1
C
MENOPAUSE
GINGIVAL DISORDER
1
C
MENOPAUSE
HEPATIC STEATOSIS
1
C
MENOPAUSE
INFLUENZA LIKE ILLNESS
1
C
MENOPAUSE
INJECTION SITE ERYTHEMA
1
C
MENOPAUSE
INJECTION SITE PRURITUS
1
C
MENOPAUSE
NAUSEA
1
C
MENOPAUSE
OEDEMA PERIPHERAL
1
C
MENOPAUSE
POST PROCEDURAL HAEMATOMA
1
C
MENOPAUSE
SNEEZING
1
C
MENOPAUSE
ULCER
1
C
MENOPAUSE
VOMITING
1
C
MENOPAUSE
WEIGHT INCREASED
1
C
MULTIPLE SCLEROSIS
ALANINE AMINOTRANSFERASE INCREASED
1
C
MULTIPLE SCLEROSIS
ANAEMIA POSTOPERATIVE
1
C
MULTIPLE SCLEROSIS
ANGIOPLASTY
1
C
MULTIPLE SCLEROSIS
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
MULTIPLE SCLEROSIS
ASTHENIA
1
C
MULTIPLE SCLEROSIS
BACK PAIN
1
C
MULTIPLE SCLEROSIS
BLOOD ALKALINE PHOSPHATASE INCREASED
1
C
MULTIPLE SCLEROSIS
BONE DISORDER
1
C
MULTIPLE SCLEROSIS
DIARRHOEA
1
C
MULTIPLE SCLEROSIS
GAMMA-GLUTAMYLTRANSFERASE INCREASED
1
C
MULTIPLE SCLEROSIS
GASTROOESOPHAGEAL REFLUX DISEASE
1
C
MULTIPLE SCLEROSIS
GINGIVAL DISORDER
1
C
MULTIPLE SCLEROSIS
HEPATIC STEATOSIS
1
C
MULTIPLE SCLEROSIS
INFLUENZA LIKE ILLNESS
1
C
MULTIPLE SCLEROSIS
INJECTION SITE ERYTHEMA
1
C
MULTIPLE SCLEROSIS
INJECTION SITE PRURITUS
1
C
MULTIPLE SCLEROSIS
NAUSEA
1
C
MULTIPLE SCLEROSIS
OEDEMA PERIPHERAL
1
C
MULTIPLE SCLEROSIS
POST PROCEDURAL HAEMATOMA
1
C
MULTIPLE SCLEROSIS
SNEEZING
1
C
MULTIPLE SCLEROSIS
ULCER
1
C
MULTIPLE SCLEROSIS
VOMITING
1
C
MULTIPLE SCLEROSIS
WEIGHT INCREASED
1
C
PRODUCT USED FOR UNKNOWN INDICATION
DRUG DEPENDENCE
19
C
PRODUCT USED FOR UNKNOWN INDICATION
DRUG WITHDRAWAL SYNDROME
19
C
PRODUCT USED FOR UNKNOWN INDICATION
SUBSTANCE ABUSE
19
C
PROPHYLAXIS
FISTULA
2
C
PROPHYLAXIS
INCISION SITE INFECTION
2
C
PROPHYLAXIS
INTESTINAL OBSTRUCTION
2
C
PROPHYLAXIS
INTESTINAL STENOSIS
2
C
PROPHYLAXIS
NEURALGIA
2
C
PSORIATIC ARTHROPATHY
ARTHRITIS
1
C
PSORIATIC ARTHROPATHY
WEIGHT INCREASED
1
C
THYROID DISORDER
FISTULA
1
C
THYROID DISORDER
INCISION SITE INFECTION
1
C
THYROID DISORDER
INTESTINAL OBSTRUCTION
1
C
THYROID DISORDER
INTESTINAL STENOSIS
1
C
THYROID DISORDER
NEURALGIA
1
C
TOOTHACHE
DRUG DEPENDENCE
1
C
TOOTHACHE
DRUG WITHDRAWAL SYNDROME
1
C
TOOTHACHE
SUBSTANCE ABUSE
1
Ads by Google